Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
4 results
  • Thyroid Cancer, Lung Cancer, Head and Neck Cancer

17-241          Phase I

A Phase 1/2 Study of Oral LOXO-292 in Patients with Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation (LIBRETTO-001) (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Lung Cancer, Sarcoma, Thyroid Cancer

17-481          Phase II

A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers (View details on clinicaltrial.gov)

  • Thyroid Cancer, Lung Cancer, Head and Neck Cancer

19-804          Phase II

A phase 1/2 study of TPX-0046,a novel oral RET/SRC inhibitor in adult subjects with advanced/metastatic solid tumors harboring oncogenic RET fusions or mutations (View details on clinicaltrial.gov)

  • Thyroid Cancer

16-616          Phase II

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers (View details on clinicaltrial.gov)

Showing 1 - 10 of 4 results